English
Insider transactions
EDGARREVANCE THERAPEUTICS, INC.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-22.
- Open-market purchases (code P)
- 0 transactions, — shares
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
This issuer has insider filings in the store, but no transaction in this window or code group.
Latest reported holdings
What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.
| Reporting owner | Security | Shares owned after | Direct or indirect | Source |
|---|---|---|---|---|
| Beraud Jill Director | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Coric Vlad Director | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Foley Mark J Director · Officer: CEO | Common Stock | 110,913 | I See footnote | As of 2025-02-05 Open filing 4 |
| Foley Mark J Director · Officer: President CEO | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Foley Mark J Director · Officer: President CEO | Common Stock | 0 | I See footnote | As of 2025-02-04 Open filing 4 |
| Gangolli Julian S Director | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Hollander David Officer: CMO Global Therapeutics Lead | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Jordan Erica Officer: Chief Commercial Officer | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Kolaja Carey OConnor Director | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Moxie Dwight Officer: CLO GC | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Nolet Chris Director | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Russell Angus C. Director | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Schilke Tobin Officer: CFO | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
| Ware Olivia C Director | Common Stock | 0 | D | As of 2025-02-06 Open filing 4 |
Joint filers each report the same shares, so rows are not added together.
Institutional holders (Form 13F)
No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.
Institutional ownership reported on Form 13F
No percent is shown: the cover-page share count is not available for this company.
- The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
- Neither includes holders that do not file Form 13F, or managers below the filing threshold.
| Quarter | Managers holding | Shares, at least | Shares, at most | Filings read |
|---|---|---|---|---|
| 2026-09-30 | 0 | 0 | 0 | 8,935 |
| 2026-06-30 | 0 | 0 | 0 | 9,178 |
| 2026-03-31 | 0 | 0 | 0 | 9,173 |
| 2025-12-31 | 0 | 0 | 0 | 9,222 |
| 2025-09-30 | 1 | 0 | 173,355 | 8,469 |
| 2025-06-30 | 1 | 0 | 3,705 | 8,516 |
| 2025-03-31 | 2 | 0 | 86,100 | 8,518 |
| 2024-12-31 | 177 | 34,849,172 | 84,738,045 | 8,580 |
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Beryl Capital Management LLC Common Stock, par value $0.001 per share | 1.6 | 1,642,448 | — Filed 2024-09-16 | SC 13GRead from the cover page text | Open filing 0000935836-24-000588 Dispute this row |
| Beryl Capital Management LP Common Stock, par value $0.001 per share | 1.6 | 1,642,448 | — Filed 2024-09-16 | SC 13GRead from the cover page text | Open filing 0000935836-24-000588 Dispute this row |
| Beryl Capital Partners II LP Common Stock, par value $0.001 per share | 1.3 | 1,412,133 | — Filed 2024-09-16 | SC 13GRead from the cover page text | Open filing 0000935836-24-000588 Dispute this row |
| David A. Witkin Common Stock, par value $0.001 per share | 1.6 | 1,642,448 | — Filed 2024-09-16 | SC 13GRead from the cover page text | Open filing 0000935836-24-000588 Dispute this row |
| Capital World Investors Common Stock | 6.6 | 6,948,769 | — Filed 2024-09-09 | SC 13G/AAmendment 4Read from the cover page text | Open filing 0001562230-24-000029 Dispute this row |
| JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share | 2.6 | 2,768,691 | — Filed 2024-04-09 | SC 13G/AAmendment 10Read from the cover page text | Open filing 0000019617-24-000305 Dispute this row |
| Polar Capital Holdings Plc Common Stock, $0.001 par value per share | 3.60 | 3,169,239 | — Filed 2024-02-13 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001172661-24-000760 Dispute this row |
| Polar Capital LLP Common Stock, $0.001 par value per share | 3.60 | 3,169,239 | — Filed 2024-02-13 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001172661-24-000760 Dispute this row |
| The Vanguard Group - 23-1945930 Name of issuer: Revance Therapeutics Inc | 5.77 | 5,069,625 | — Filed 2024-02-13 | SC 13G/AAmendment 2Read from the cover page text | Open filing 0001104659-24-021835 Dispute this row |
| Capital World Investors Common Stock | 13.6 | 11,939,076 | — Filed 2024-02-09 | SC 13G/AAmendment 3Read from the cover page text | Open filing 0001422848-24-000290 Dispute this row |
| GIC Private Limited Common Stock, par value $0.001 per share | 6.63 | 5,825,881 | — Filed 2024-02-09 | SC 13G/AAmendment 4Read from the cover page text | Open filing 0001140361-24-006576 Dispute this row |
| JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share | 5.4 | 4,754,771 | — Filed 2024-01-25 | SC 13G/AAmendment 09Read from the cover page text | Open filing 0000019617-24-000156 Dispute this row |
| BlackRock, Inc. Common Stock | 8.5 | 7,453,371 | — Filed 2024-01-25 | SC 13G/AAmendment 8Read from the cover page text | Open filing 0001086364-24-003237 Dispute this row |
| JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share | 5.4 | 4,754,771 | — Filed 2024-01-25 | SC 13G/AAmendment 09Read from the cover page text | Open filing 0000019617-24-000145 Dispute this row |
| Teoxane SA Common Stock, par value $0.001 per share | 7.4 | 6,550,800 | — Filed 2023-10-24 | SC 13D/AAmendment 1Read from the cover page text | Open filing 0001140361-23-049319 Dispute this row |
| Teoxane SA Common Stock, par value $0.001 per share | 5.0 | 4,445,800 | — Filed 2023-09-01 | SC 13DRead from the cover page text | Open filing 0001140361-23-042206 Dispute this row |
| Antara Capital LP Common Stock, $.001 par value | 6.4 | 5,239,600 | — Filed 2023-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-23-037217 Dispute this row |
| Antara Capital GP LLC Common Stock, $.001 par value | 6.4 | 5,239,600 | — Filed 2023-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-23-037217 Dispute this row |
| Himanshu Gulati Common Stock, $.001 par value | 6.4 | 5,239,600 | — Filed 2023-02-14 | SC 13GRead from the cover page text | Open filing 0001193125-23-037217 Dispute this row |
| Polar Capital Holdings Plc Common Stock, $0.001 par value per share | 5.9 | 4,848,633 | — Filed 2023-02-14 | SC 13GRead from the cover page text | Open filing 0001172661-23-001298 Dispute this row |
| Polar Capital LLP Common Stock, $0.001 par value per share | 5.9 | 4,848,633 | — Filed 2023-02-14 | SC 13GRead from the cover page text | Open filing 0001172661-23-001298 Dispute this row |
| Capital World Investors Common Stock | 11.5 | 9,480,156 | — Filed 2023-02-13 | SC 13G/AAmendment 2Read from the cover page text | Open filing 0001422849-23-000128 Dispute this row |
| The Vanguard Group - 23-1945930 Name of issuer: Revance Therapeutics Inc. | 5.47 | 4,496,316 | — Filed 2023-02-09 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001104659-23-016848 Dispute this row |
| GIC Private Limited Common Stock, par value $0.001 per share | 6.68 | 5,492,965 | — Filed 2023-02-09 | SC 13G/AAmendment 3Read from the cover page text | Open filing 0001140361-23-005449 Dispute this row |
| BlackRock, Inc. Common Stock | 8.6 | 7,072,681 | — Filed 2023-02-03 | SC 13G/AAmendment 7Read from the cover page text | Open filing 0001306550-23-007655 Dispute this row |
| JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share | 6.0 | 4,982,949 | — Filed 2023-01-27 | SC 13G/AAmendment 08Read from the cover page text | Open filing 0000019617-23-000167 Dispute this row |
| Capital World Investors Common Stock | 10.3 | 8,463,909 | — Filed 2022-12-09 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001422849-22-000177 Dispute this row |
| Not recorded Common Stock | 6.09 | 4,369,366 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001306923-22-000009 Dispute this row |
| Not recorded Common Stock | 6.09 | 4,369,366 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001306923-22-000009 Dispute this row |
| Not recorded Common Stock | 6.09 | 4,369,366 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001306923-22-000009 Dispute this row |
| Not recorded Common Stock | 6.09 | 4,369,366 | — Filed 2022-02-14 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001306923-22-000009 Dispute this row |
| Capital World Investors Common Stock | 5.2 | 3,712,000 | — Filed 2022-02-11 | SC 13GRead from the cover page text | Open filing 0001422849-22-000132 Dispute this row |
| The Vanguard Group - 23-1945930 Name of issuer: Revance Therapeutics Inc. | 5.02 | 3,602,297 | — Filed 2022-02-10 | SC 13GRead from the cover page text | Open filing 0001104659-22-018458 Dispute this row |
| GIC Private Limited Common Stock, par value $0.001 per share | 5.82 | 4,176,080 | — Filed 2022-02-08 | SC 13G/AAmendment 2Read from the cover page text | Open filing 0001193125-22-031120 Dispute this row |
| Wellington Management Group LLP Common Stock | 1.54 | 1,104,531 | — Filed 2022-02-04 | SC 13G/AAmendment 7Read from the cover page text | Open filing 0001678858-22-000336 Dispute this row |
| Wellington Group Holdings LLP Common Stock | 1.54 | 1,104,531 | — Filed 2022-02-04 | SC 13G/AAmendment 7Read from the cover page text | Open filing 0001678858-22-000336 Dispute this row |
| Wellington Investment Advisors Holdings LLP Common Stock | 1.54 | 1,104,531 | — Filed 2022-02-04 | SC 13G/AAmendment 7Read from the cover page text | Open filing 0001678858-22-000336 Dispute this row |
| BlackRock, Inc. Common Stock | 7.4 | 5,334,099 | — Filed 2022-02-03 | SC 13G/AAmendment 6Read from the cover page text | Open filing 0000834237-22-006351 Dispute this row |
| JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share | 9.4 | 6,794,223 | — Filed 2022-01-18 | SC 13G/AAmendment 07Read from the cover page text | Open filing 0000019617-22-000113 Dispute this row |
| ArrowMark Colorado Holdings, LLC Common Stock, par value $0.001 per share | 4.5 | 2,964,135 | — Filed 2021-02-16 | SC 13G/AAmendment 3Read from the cover page text | Open filing 0001172661-21-000642 Dispute this row |
| GIC Private Limited Common Stock, par value $0.001 per share | 5.76 | 3,830,951 | — Filed 2021-02-12 | SC 13G/AAmendment 1Read from the cover page text | Open filing 0001193125-21-041682 Dispute this row |
| BlackRock, Inc. Common Stock | 7.5 | 5,012,352 | — Filed 2021-02-05 | SC 13G/AAmendment 5Read from the cover page text | Open filing 0000834237-21-007453 Dispute this row |
| Wellington Management Group LLP Common Stock | 5.11 | 3,397,872 | — Filed 2021-02-04 | SC 13G/AAmendment 6Read from the cover page text | Open filing 0000902219-21-000299 Dispute this row |
| Wellington Group Holdings LLP Common Stock | 5.11 | 3,397,872 | — Filed 2021-02-04 | SC 13G/AAmendment 6Read from the cover page text | Open filing 0000902219-21-000299 Dispute this row |
| Wellington Investment Advisors Holdings LLP Common Stock | 5.11 | 3,397,872 | — Filed 2021-02-04 | SC 13G/AAmendment 6Read from the cover page text | Open filing 0000902219-21-000299 Dispute this row |
| Franklin Resources, Inc. Common Stock, par value $0.001 per share | 2.6 | 1,755,863 | — Filed 2021-02-02 | SC 13G/AAmendment 6Read from the cover page text | Open filing 0000038777-21-000038 Dispute this row |
| Charles B. Johnson Common Stock, par value $0.001 per share | 2.6 | 1,755,863 | — Filed 2021-02-02 | SC 13G/AAmendment 6Read from the cover page text | Open filing 0000038777-21-000038 Dispute this row |
| Rupert H. Johnson, Jr. Common Stock, par value $0.001 per share | 2.6 | 1,755,863 | — Filed 2021-02-02 | SC 13G/AAmendment 6Read from the cover page text | Open filing 0000038777-21-000038 Dispute this row |
| JPMORGAN CHASE & CO. Common Stock, par value $0.001 per share | 6.1 | 4,067,042 | — Filed 2021-01-29 | SC 13G/AAmendment 06Read from the cover page text | Open filing 0000019617-21-000180 Dispute this row |
| Wellington Management Group LLP Common Stock | 5.68 | 3,743,700 | — Filed 2020-08-10 | SC 13G/AAmendment 5Read from the cover page text | Open filing 0000902219-20-000421 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 258,595 |
| 2016 | 246,472 |
| 2017 | 244,814 |
| 2018 | 245,575 |
| 2019 | 238,619 |
| 2020 | 249,093 |
| 2021 | 274,850 |
| 2022 | 257,922 |
| 2023 | 253,676 |
| 2024 | 261,106 |
| 2025 | 235,525 |
| 2026 | 263,830 |
Filings made before the SEC required XML are listed, not extracted.